SPOTLIGHT -
Article
Cobenfy as Add-On Treatment for Schizophrenia Fails to Meet Primary Endpoint in Phase 3 ARISE Trial
Lifestyle Interventions for ADHD
Cybin Announces Partnership With Osmind to Advance Clinical-Stage Psychiatry Programs
Here's to a Psychedelic Revolution
"You Need to Help Yourself Before Helping Patients": Reducing Physician Suicide
MindMed Begins Phase 3 Emerge Study of MM120 in Patients With Major Depressive Disorder
